Sinomenine Hydrochloride Attenuates Renal Fibrosis by Inhibiting Excessive Autophagy Induced by Adriamycin: An

Ming-Ming Zhao1, Bin Yang1, Qiu Zhang1

  • 1Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.

Insights

Sinomenine hydrochloride (SIN-HCl) effectively treats adriamycin-induced renal fibrosis in rats by regulating autophagy. This compound reduces proteinuria and kidney damage by modulating fibronectin, laminin, LC3, and Beclin-1 levels.

Area of Science:

  • Nephrology
  • Pharmacology
  • Cell Biology

Background:

  • Adriamycin-induced nephropathy is a significant cause of renal fibrosis.
  • Autophagy plays a complex role in the progression of kidney disease.

Purpose of the Study:

  • To investigate the therapeutic potential of sinomenine hydrochloride (SIN-HCl) against adriamycin-induced renal fibrosis.
  • To elucidate the role of autophagy regulation in SIN-HCl's renoprotective effects.

Main Methods:

  • A rat model of adriamycin-induced renal fibrosis was established.
  • Rats were treated with SIN-HCl or telmisartan.
  • Proteinuria, renal pathology (HE, Masson, PASM staining), and expression of fibronectin, laminin, LC3, and Beclin-1 were assessed.

Main Results:

  • SIN-HCl treatment ameliorated proteinuria and attenuated renal pathological changes.
  • SIN-HCl reduced the expression of fibronectin, laminin, LC3, and Beclin-1, indicating reduced fibrosis and excessive autophagy.
  • The drug inhibited adriamycin-induced excessive autophagy while upregulating basal autophagy.

Conclusions:

  • Sinomenine hydrochloride demonstrates significant renoprotective effects against adriamycin-induced renal fibrosis.
  • Regulation of autophagy is a key mechanism by which SIN-HCl exerts its therapeutic benefits.
  • SIN-HCl represents a potential therapeutic agent for managing kidney fibrosis.